Charles Bosworth

Chief Medical Officer @Azura Ophthalmics Limited

Las Vegas, NV, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2017 — Present

Chief Medical Officer @Azura Ophthalmics Limited

View department →

Azura Ophthalmics Ltd.(Azura) is a clinical-stage biotechnology company developing innovative therapies for meibomian gland dysfunction (MGD). Azura has completed a $16 million Series B funding round led by a syndicate of OrbiMed, TPG Biotech and Brandon Capital’s Medical Research Commercialisation Fund with participation from an existing investor Ganot Capital.

EDUCATION

1990 — 1999

University of California, San Diego

PhD, Visual Psychophysics/Ophthalmology

SKILLS

Clinical MonitoringClinical ResearchR&DDrug DeliveryClinical Study DesignCROOncologySopRegulatory AffairsCtmsClinical DevelopmentTechnology TransferRegulatory SubmissionsMedical AffairsMedical DevicesDrug DiscoveryBiopharmaceuticalsIndGlpClinical TrialsPharmaceutical IndustryIch-GcpOphthalmologyClinical Data ManagementProtocolDrug DevelopmentMedical WritingEdcNeuroscienceLife SciencesGcpTherapeutic Areas21 Cfr Part 11PharmacovigilanceLifesciences

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Charles Bosworth — Chief Medical Officer at Azura Ophthalmics Limited in Las Vegas, NV, US | Unifers